Liquid-Based Cytology Systems and High-Risk Human Papillomavirus Testing Systems for Cervical Cancer

Descriptions

NHS Supply Chain seeks to establish a comprehensive, non-exclusive, framework agreement for the supply to the NHS supply chain customer base via the E-Direct/Direct Route of Liquid-Based Cytology Systems and High-Risk Human Papillomavirus Testing Systems for Cervical Cancer Screening.NHS supply chain may (but shall not be required to) purchase the goods subject to the framework agreement using any of the following methods:— reagent rental,— capital purchases,— reagents only (with or without commitment),— equipment only (with or without commitment), including short term extensions,— managed services.Contracts may be awarded (subject to meeting the appropriate criteria as specified within the ITT Documentation) either via direct award or via further competition.